Who We Are
About HyGyHya
We exist to solve the most consequential unsolved problem in cannabinoid medicine: stability. Without stable cannabinoids, there is no safe dose, no reliable shelf life, and no regulatory pathway.
Our Mission
Advancing Cannabinoid Medicine Through Science
HyGyHya was founded on a single conviction: the therapeutic promise of cannabinoid medicine cannot be realised without first solving the chemistry. The Micro Bio-Shield platform is our answer.
Our technology prevents cannabinoid degradation, eliminates THC conversion risk, and produces batch-consistent output that meets Standard Reference Material requirements — opening the door to legitimate pharmaceutical development and global commercial scale.
Scientific Integrity
Every formulation we produce is grounded in rigorous peer-reviewed chemistry, not marketing claims. We hold ourselves to pharmaceutical-grade standards in every batch.
Global Access
We design our technology to meet international regulatory frameworks so that safe, stable cannabinoid medicine can reach patients and practitioners worldwide.
Transparent Partnership
We work alongside our B2B partners with full transparency, sharing the science behind every product so our partners can confidently represent our technology.
The Technology
Micro Bio-Shield: Proprietary Stabilisation
A patent-protected encapsulation and stabilisation matrix that shields cannabinoid molecules from the environmental factors that drive degradation: light, heat, oxidation, and time.
3×+
Shelf life extension vs unprotected CBD
0%
THC conversion across all tested batches
SRM
Standard Reference Material compliant output
GRAS
Exclusively GRAS-certified excipients
The result is a cannabinoid preparation that remains potent, pure, and THC-free far beyond the benchmarks set by any existing formulation — enabling pharmaceutical-grade products that meet global regulatory standards.